Carotid Intervention
Washington Convention Center, Lower Level, Hall A Saturday, September 13, 2014, 5:00 PM-7:00 PM Abstract nos: 548-564 Proximal occlusion versus distal filter for cerebral protection during carotid stenting: a meta-analysis of MRI studies Background: Proximal occlusion (PO) and distal filter (DF) serve for cerebral embolic protection during carotid artery stenting (CAS). The incidence of new cerebral lesions at diffusion-weighted magnetic resonance imaging (DW-MRI) represents a surrogate endpoint for embolization, though the clinical impact is controversial. We perform a meta-analysis of DW-MRI studies comparing PO and DF during CAS. Methods: Scientific databases and websites were searched. The primary endpoint was the incidence of new cerebral lesions at DW-MRI; secondary endpoints were the incidence of new ipsilateral and new contralateral cerebral lesions at DW-MRI and death/cerebrovascular events (CVE). Background: Carotid stenting (CS) is considered to be non-inferior to carotid endarterectomy (CEA) for treatment of symptomatic carotid disease with similar stoke and death rates. It is still to be determined if staged CS followed by CABG could be also non-inferior to combined CEA and CABG for the concomitant presence of coronary and carotid artery disease. Therefore we aimed to evaluate the non-inferiority of staged CS compared to combined CEA and CABG by using all the prospective available studies. Methods: Pub Med, Chocrane and Scopus were systematically searched up to April 2014. Subjects of analysis were 30 days post surgery incidence of stroke and death for carotid and coronary revascularization using either CS or CEA with CABG. We used Fixed or Random Effect analysis using the Cochrane Handbook of Systematic Reviews. Results: Out of 350 articles, three prospective studies were identified and disclosed a total of 94 patients on the CS and 140 in the CEA group respectively. There was a trend towards lower stroke in the CAS group compared to the CEA (4.2% vs 9.2%, p¼0.1; Figure 1 .A) and no difference on mortality rate (5.3% vs. 7.8%, p¼0.42; Figure 1 .B). Conclusions: Our analysis suggests that staged CS and CABG might not be inferior to combined CEA and CABG. Also the overall mean incidence of 30 days stroke is below the average reported on most observational studies. Therefore clinical randomized studies are warranted.
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